Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;19(4):279-286.
doi: 10.14744/AnatolJCardiol.2017.8170. Epub 2018 Mar 13.

Fulminant myocarditis: Characteristics, treatment, and outcomes

Affiliations

Fulminant myocarditis: Characteristics, treatment, and outcomes

Giacomo Veronese et al. Anatol J Cardiol. 2018 Apr.

Abstract

Myocarditis is an inflammatory disease of the myocardium with a broad spectrum of clinical presentations, ranging from mild symptoms to severe heart failure. The course of patients with myocarditis is heterogeneous, varying from partial or full clinical recovery in few days to advanced low cardiac output syndrome requiring mechanical circulatory support or heart transplantation. Fulminant myocarditis (FM) is a peculiar clinical condition and is an acute form of myocarditis, whose main characteristic is a rapidly progressive clinical course with the need for hemodynamic support. Despite the common medical belief of the past decades, recent comprehensive data, including a recent registry that compared FM with acute non-FM, highlighted that FM has a poor inhospital outcome, often requires advanced hemodynamic support, and may result in residual left ventricular dysfunction in survivors. This review aimed to provide an updated practical definition of FM, including essentials in the diagnosis and management of the disease. Finally, the outcome of FM was critically revised according to the current published registries focusing on the topic.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Cooper LT., Jr Myocarditis. N Engl J Med; 360:1526–38. - PMC - PubMed
    1. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012;379:738–47. - PMC - PubMed
    1. Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med. 2016;375:1749–55. - PMC - PubMed
    1. Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98:835–40. - PubMed
    1. Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, et al. Myocarditis in Clinical Practice. Mayo Clin Proc. 2016;91:1256–66. - PubMed

LinkOut - more resources